Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose mass balance and metabolism study of [14C]GW642444 in healthy male volunteers
NL-OMON34294Active, not recruiting
- Sponsor
- GSK
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of vilanterol in asthma and chronic obstructive pulmonary disease (COPD), sponsored by GSK. Primary endpoints: Plasma total radioactivity relative to parent GW642444 concentration, Urinary and fecal excretion of total radioactivity and 1 more. Started May 2010; status: active, not recruiting.
02
Drugs
vilanterol
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON34294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34294.